Paul F Truex's Net Worth
-$33.8 Thousand
Who is Paul F Truex?
Paul F Truex does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trius Therapeutics Inc, CymaBay Therapeutics, Inc., Milestone Pharmaceuticals Inc., and Anthera Pharmaceuticals Inc.
SEC CIK
Paul F Truex's CIK is 0001120362
Past Insider Trading and Trends
2022 was Paul F Truex's most active year for acquiring shares with 5 total transactions. Paul F Truex's most active month to acquire stocks was the month of April. 2013 was Paul F Truex's most active year for disposing of shares, totalling 6 transactions. Paul F Truex's most active month to dispose stocks was the month of August. 2022 saw Paul F Truex paying a total of $143,795.12 for 81,780 shares, this is the most they've acquired in one year. In 2013 Paul F Truex cashed out on 74,673 shares for a total of $521,670.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trius Therapeutics Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.27K |
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
| +17.75% | 2K |
$6.80 | $13,600.00 | 13.27K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +287.82% | 8.36K |
$1.55 | $12,999.56 | 11.27K |
Nov 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CymaBay Therapeutics, Inc. (CBAY) Snapshot price: $24.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 81.78K |
$1.76 | $143,795.12 | 81.78K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anthera Pharmaceuticals Inc No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +1.25% | 1.14K |
$3.30 | -$8,989.20 | 92.03K |
Jun 30 - Mar 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||